Incannex Healthcare Ltd (ASX: IHL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Incannex Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $429.03 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 1.21 billion
Earnings per share -0.006
Dividend per share N/A
Year To Date Return 125.81%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Incannex Healthcare Ltd (ASX: IHL)
Latest News

IHL ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Incannex Healthcare Ltd

Formerly Mount Magnet South Limited (MUM), 28/10/2016; Impression Healthcare Limited (IHL), 03/07/2020.

IHL Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
14 Oct 2021 $0.36 $0.01 2.86% 1,374,365 $0.36 $0.36 $0.35
13 Oct 2021 $0.35 $0.01 2.90% 769,537 $0.35 $0.36 $0.35
12 Oct 2021 $0.35 $-0.01 -2.86% 1,830,579 $0.35 $0.37 $0.35
11 Oct 2021 $0.35 $0.01 2.94% 833,688 $0.34 $0.36 $0.34
08 Oct 2021 $0.34 $0.01 3.03% 1,264,424 $0.34 $0.36 $0.34
07 Oct 2021 $0.33 $0.00 0.00% 2,575,606 $0.33 $0.35 $0.33
06 Oct 2021 $0.33 $-0.01 -2.99% 1,510,237 $0.34 $0.35 $0.33
05 Oct 2021 $0.34 $-0.01 -2.90% 3,187,896 $0.35 $0.35 $0.33
04 Oct 2021 $0.35 $-0.01 -2.86% 1,177,327 $0.36 $0.37 $0.35
01 Oct 2021 $0.35 $0.00 0.00% 2,388,016 $0.35 $0.36 $0.34
30 Sep 2021 $0.35 $-0.01 -2.82% 2,009,508 $0.36 $0.36 $0.35
29 Sep 2021 $0.36 $-0.01 -2.78% 1,698,820 $0.35 $0.37 $0.35
28 Sep 2021 $0.36 $0.01 2.82% 2,173,978 $0.36 $0.38 $0.35
27 Sep 2021 $0.36 $-0.02 -5.33% 2,433,107 $0.37 $0.37 $0.35
24 Sep 2021 $0.38 $0.00 0.00% 1,423,457 $0.38 $0.38 $0.37
23 Sep 2021 $0.38 $0.02 5.63% 2,129,358 $0.36 $0.38 $0.35
22 Sep 2021 $0.36 $-0.01 -2.74% 2,000,981 $0.37 $0.37 $0.35
21 Sep 2021 $0.37 $0.01 2.82% 5,070,182 $0.35 $0.38 $0.33
20 Sep 2021 $0.36 $-0.05 -12.50% 7,929,101 $0.40 $0.40 $0.34
17 Sep 2021 $0.40 $-0.01 -2.44% 4,506,649 $0.42 $0.43 $0.39
16 Sep 2021 $0.41 $0.02 5.06% 2,247,221 $0.40 $0.41 $0.39
15 Sep 2021 $0.40 $0.01 2.56% 3,070,800 $0.39 $0.41 $0.39

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
06 Oct 2021 Sudhanshu Agarwal Buy 20 $4,199,900
Exercise of options.
06 Oct 2021 Sudhanshu Agarwal Exercise 20 $4,199,900
Exercise of options. As per announcement on 07/10/2021
21 Sep 2021 Troy Valentine Buy 7 $569,356
Exercise of options.
21 Sep 2021 Troy Valentine Exercise 7 $569,356
Exercise of options.
21 Sep 2021 Peter Widdows Exercise 657 $52,631
Exercise of options.
21 Sep 2021 Peter Widdows Buy 657 $52,631
Exercise of options.
06 Sep 2021 Joel Latham Exercise 200 $16,000
Exercise of options.
06 Sep 2021 Joel Latham Buy 200 $16,000
Exercise of options.
06 Sep 2021 Sudhanshu Agarwal Buy 20 $4,000,000
Exercise of options.
06 Sep 2021 Sudhanshu Agarwal Exercise 20 $4,000,000
Exercise of options.
30 Jun 2021 Sudhanshu Agarwal Expiry 2 $500,000
As advised by the company. Lapse of performance rights
30 Jun 2021 Joel Latham Expiry 5 $1,250,000
As advised by the company. As per announcement on 01/07/2021.
Lapse of performance rights
30 Jun 2021 Troy Valentine Expiry 1 $375,000
As advised by the company. Lapse of performance rights
30 Jun 2021 Peter Widdows Expiry 1 $375,000
As advised by the company. As per announcement on 01/07/2021
Lapse of performance rights
03 May 2021 Peter Widdows Sell 600 $195,000
On-market trade.
03 May 2021 Peter Widdows Buy 600 $195,000
On-market trade.
25 Feb 2021 Sudhanshu Agarwal Buy 12 $2,648,198
Conversion of securities.
25 Feb 2021 Sudhanshu Agarwal Exercise 12 $2,648,198
Conversion of securities. 2,000,000 - performance rights
16 Dec 2020 Sudhanshu Agarwal Exercise 9 $1,504,487
Conversion of securities. 14,037,265 - performance rights
16 Dec 2020 Sudhanshu Agarwal Buy 9 $1,504,487
Conversion of securities.
03 Dec 2020 Sudhanshu Agarwal Buy 7 $1,053,175
Conversion of securities.
03 Dec 2020 Sudhanshu Agarwal Expiry 88 $12,760,000
Options expired. As per announcement on 04/12/2020.
03 Dec 2020 Sudhanshu Agarwal Exercise 7 $1,053,175
Conversion of securities. 23,440,313 - performance rights
19 Oct 2020 Sudhanshu Agarwal Exercise 1 $148,800
Conversion of securities. 30,703,593 - performance rights
As per announcement on 19/10/2020.
19 Oct 2020 Sudhanshu Agarwal Buy 1 $148,800
Conversion of securities. As per announcement on 19/10/2020.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Troy Robert Valentine Non-Executive ChairmanNon-Executive Director Dec 2017
Mr Valentine has 26 years' experience in Stockbroking, Corporate Finance and Capital Markets. He began with Hartley Poynton (now Hartley's Limited) in 1994 before moving to Patersons Securities (Perth) in 2000 and transferring to Patersons Melbourne where he became an Associate Director of Private Clients. During this time, he was responsible for managing both retail and institutional accounts. Mr Valentine has Corporate and Capital raising experience with start-ups and small to mid-cap size companies. He is currently a director of Corporate Advisory Alignment Capital Pty Ltd which he co-founded in 2014.
Mr Peter Widdows Non-Executive Director Mar 2018
Mr Widdows is the former Regional CEO of the H. J. Heinz corporation of Asia and Australasia. He has experience in Australian and international consumer goods markets and has worked as a senior executive/CEO in Europe, the USA and Asia/Pacific. He is the current Non-executive Chair of Sunny Queen Australia Ltd.
Mr Joel Bradley Latham Chief Executive OfficerExecutive DirectorManaging Director Jul 2018
Mr Latham has over 14 years' experience with various companies like Mars Foods, Tabcorp and Philip Morris International.
Mr Sudhanshu Agarwal Non-Executive Director Jul 2019
Dr Agarwal has experience in three healthcare businesses and also sees business opportunities at their earliest stage and builds teams. He also serves as CEO/ Chairman of Cannvalate.
Mr Madhukar (Madhu) Bhalla Company Secretary Jul 2021
-
Madhukar (Madhu) Bhalla Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Cannvalate Pty Ltd 32,000,000 4.20%
CS Third Nominees Pty Limited 30,916,693 4.06%
Mr Anthony Michael Malyniak 24,500,000 3.21%
Cipater Pty Ltd 19,200,000 2.52%
Footprint Capital Pty Limited 18,200,000 2.39%
Miss Francine Elizabeth Planet 17,562,500 2.30%
EZR Systems Pty Ltd 17,309,187 2.27%
Mr Brian Peter Byass 16,210,000 2.13%
Bagbo Pty Ltd 15,750,696 2.07%
Slade Technologies Pty Ltd 14,676,316 1.93%
Mr Peter Widdows 12,615,790 1.66%
Mr Joel Bradley Latham 11,829,129 1.55%
Alignment Capital Pty Ltd 11,194,248 1.47%
JAPL Nominees Pty Ltd 10,004,370 1.31%
Mr Peter Francis Scanlan 9,178,958 1.20%
Guina Nominees Pty Ltd 8,650,000 1.14%
Portcullis House Pty Ltd 6,410,260 0.84%
Alistair Pty Ltd 6,000,000 0.79%
Derahn Nominees Pty Ltd 5,901,137 0.77%
Ellaz Pty Ltd 5,095,000 0.67%

Profile

since

Note